"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
TO ARTICLE
METRICS

Case report
peer-reviewed

Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine


Total Article Reads

Article reads consist of online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Total Article Reads Cureus PMC
218,848 Article Views 101,767 109,545
PDF Downloads 4,419 3,117
Total Article Reads Cureus PMC
218,848 Article Views 101,767 109,545
PDF Downloads 4,419 3,117
Total Article Reads
218,848
Cureus PMC
Article Views 101,767 109,545
PDF Downloads 4,419 3,117

Article Reads by Date

Hover your cursor over a specific day or month to see the corresponding online article views and PDF downloads. Cureus data is delayed by 24 hours and PMC data is delayed by approximately one month.

Cureus Article Reads

Loading...

Cumulative Cureus and PMC Article Reads

Loading...

Article Reads by Country

Hover your cursor over a country to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank Country Views Percentage

Article Reads by U.S. States

Hover your cursor over a state to see the number of online article views and PDF downloads from Cureus only.
Note: PMC does not share location data and not all Cureus reads are included below as location data is not available for all IP addresses.


Rank State Views Percentage

Citations

Citation index reporting varies. Crossref citations are listed below and Google Scholar citations can be seen by clicking the corresponding button.

Google Scholar  
Crossref Citations (47)
  1. Rohilla, R., Kakkar, A. K., Divyashree, K., Mohindra, R., & Suri, V. (2022). Recombinant protein subunit COVID‐19 Vaccine Induced Guillain‐Barre Syndrome in an adolescent: A case report. British Journal of Clinical Pharmacology. Portico. https://doi.org/10.1111/bcp.15466 doi:10.1111/bcp.15466.
  2. Tozinameran. (2022). Reactions Weekly, 1917(1), 547–547. https://doi.org/10.1007/s40278-022-20418-0 doi:10.1007/s40278-022-20418-0.
  3. Rabinowitz, K., Navon, M., Edelman-Klapper, H., Zittan, E., Bar-Gil Shitrit, A., Goren, I., Avni-Biron, I., Ollech, J., Lichtenstein, L., Banai-Eran, H., Yanai, H., Snir, Y., Pauker, M., Friedenberg, A., Levy-Barda, A., Segal, A., Broitman, Y., Maoz, E., … Ovadia, B. (2022). Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases. Vaccines, 10(8), 1186. https://doi.org/10.3390/vaccines10081186 doi:10.3390/vaccines10081186.
  4. Atzenhoffer, M., Auffret, M., Pegat, A., Masmoudi, K., Khouri, C., Bertin, B., & Vial, T. (2022). Guillain–Barré Syndrome Associated with COVID-19 Vaccines: A Perspective From Spontaneous Report Data. Clinical Drug Investigation. https://doi.org/10.1007/s40261-022-01164-4 doi:10.1007/s40261-022-01164-4.
  5. Bramer, S., Jaffe, Y., & Sivagnanaratnam, A. (2022). Vestibular neuronitis after COVID-19 vaccination. BMJ Case Reports, 15(6), e247234. https://doi.org/10.1136/bcr-2021-247234 doi:10.1136/bcr-2021-247234.
  6. Hossain, M. A., Rashid, Md. U., Barsha, S. Y., Khan, Md. A. S., Haque, M. Md. A., Rahman, M. L., Hossian, M., Bhuiyan, A. M., Nabi, M. H., & Hawlader, M. D. H. (2022). Case Report: Acute myocardial infarction with acute left ventricular failure and acute renal damage following mRNA-1273 vaccination: Possible adverse effect of COVID-19 vaccination? F1000Research, 11, 617. https://doi.org/10.12688/f1000research.109496.1 doi:10.12688/f1000research.109496.1.
  7. Chua, S., Soh, Q., Saffari, S., & Tan, E.-K. (2022). Prognosis of Guillain–Barré Syndrome Linked to COVID-19 Vaccination. Brain Sciences, 12(6), 711. https://doi.org/10.3390/brainsci12060711 doi:10.3390/brainsci12060711.
  8. Banamah, T. A., Bogari, A. A., Neyazi, A., Kotbi, E., Almaghraby, H., & Atwah, F. (2022). Severe Rhabdomyolysis Complicated With Acute Kidney Injury Required Renal Replacement Therapy After Pfizer COVID-19 Vaccine  . Cureus. https://doi.org/10.7759/cureus.25199 doi:10.7759/cureus.25199.
  9. Sarvilina, I. V., Lila, A. M., Gromova, O. A., Torshin, I. Yu., Shavlovskaya, O. A., & Taskina, E. A. (2022). Analysis of the mechanisms of development of neurorheumatological consequences of COVID-19 and the possibility of their pharmacological correction. Modern Rheumatology Journal, 16(2), 92–98. https://doi.org/10.14412/1996-7012-2022-2-92-98 doi:10.14412/1996-7012-2022-2-92-98.
  10. Carranza, O., Babici, D., Waheed, S., & Yousuf, F. (2022). Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination. Cureus. https://doi.org/10.7759/cureus.24252 doi:10.7759/cureus.24252.
  11. Carranza, O., Babici, D., Waheed, S., & Yousuf, F. (2022). Neurologic Sequela of COVID-19: Guillain-Barré Syndrome Following Johnson & Johnson COVID-19 Vaccination. Cureus. https://doi.org/10.7759/cureus.24252 doi:10.7759/cureus.24252.
  12. Kubota, T., Hasegawa, T., Ikeda, K., & Aoki, M. (2022). Case Report: Isolated, unilateral oculomotor palsy with anti-GQ1b antibody following COVID-19 vaccination. F1000Research, 10, 1142. https://doi.org/10.12688/f1000research.74299.2 doi:10.12688/f1000research.74299.2.
  13. Yamakawa, M., Nakahara, K., Nakanishi, T., Nomura, T., & Ueda, M. (2022). Miller Fisher Syndrome Following Vaccination against SARS-CoV-2. Internal Medicine, 61(7), 1067–1069. https://doi.org/10.2169/internalmedicine.8851-21 doi:10.2169/internalmedicine.8851-21.
  14. Sriwastava, S., Sharma, K., Khalid, S. H., Bhansali, S., Shrestha, A. K., Elkhooly, M., Srivastava, S., Khan, E., Jaiswal, S., & Wen, S. (2022). COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sciences, 12(3), 407. https://doi.org/10.3390/brainsci12030407 doi:10.3390/brainsci12030407.
  15. Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., Reyes, C., Strauss, V., Prieto-Alhambra, D., Burn, E., & Duarte-Salles, T. (2022). Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ, e068373. https://doi.org/10.1136/bmj-2021-068373 doi:10.1136/bmj-2021-068373.
  16. Taga, A., & Lauria, G. (2022). COVID ‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era. Journal of the Peripheral Nervous System. Portico. https://doi.org/10.1111/jns.12482 doi:10.1111/jns.12482.
  17. Cau, R., Mantini, C., Monti, L., Mannelli, L., Di Dedda, E., Mahammedi, A., Nicola, R., Roubil, J., Suri, J. S., Cerrone, G., Fanni, D., Faa, G., Carriero, A., Scuteri, A., Francone, M., & Saba, L. (2022). Role of imaging in rare COVID-19 vaccine multiorgan complications. Insights into Imaging, 13(1). https://doi.org/10.1186/s13244-022-01176-w doi:10.1186/s13244-022-01176-w.
  18. Masuccio, F. G., Comi, C., & Solaro, C. (2021). Guillain–Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report. Acta Neurologica Belgica. https://doi.org/10.1007/s13760-021-01838-4 doi:10.1007/s13760-021-01838-4.
  19. Nishiguchi, Y., Matsuyama, H., Maeda, K., Shindo, A., & Tomimoto, H. (2021). Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurology, 21(1). https://doi.org/10.1186/s12883-021-02489-x doi:10.1186/s12883-021-02489-x.
  20. Sriwastava, S., Shrestha, A. K., Khalid, S. H., Colantonio, M. A., Nwafor, D., & Srivastava, S. (2021). Spectrum of Neuroimaging Findings in Post-COVID-19 Vaccination: A Case Series and Review of Literature. Neurology International, 13(4), 622–639. https://doi.org/10.3390/neurolint13040061 doi:10.3390/neurolint13040061.
  21. Prasad, A., Hurlburt, G., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021). A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination. Neurology International, 13(3), 404–409. https://doi.org/10.3390/neurolint13030040 doi:10.3390/neurolint13030040.
  22. Wang, F., Wang, D., Wang, Y., Li, C., Zheng, Y., Guo, Z., Liu, P., Zhang, Y., Wang, W., Wang, Y., & Hou, H. (2022). Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.782198 doi:10.3389/fimmu.2022.782198.
  23. Zubair, A. S., Bae, J. Y., & Desai, K. (2022). Facial Diplegia Variant of Guillain-Barré Syndrome in Pregnancy Following COVID-19 Vaccination: A Case Report. Cureus. https://doi.org/10.7759/cureus.22341 doi:10.7759/cureus.22341.
  24. Assiri, S. A., Althaqafi, R. M., Alswat, K., Alghamdi, A., Alomairi, N. E., Nemenqani, D. M., Ibrahim, Z. S., & Elkady, A. (2022). Post COVID-19 Vaccination-Associated Neurological Complications. Neuropsychiatric Disease and Treatment, Volume 18, 137–154. https://doi.org/10.2147/ndt.s343438 doi:10.2147/NDT.S343438.
  25. Noseda, R., Ripellino, P., Ghidossi, S., Bertoli, R., & Ceschi, A. (2021). Reporting of Acute Inflammatory Neuropathies with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase. Vaccines, 9(9), 1022. https://doi.org/10.3390/vaccines9091022 doi:10.3390/vaccines9091022.
  26. N Sheehan, K., & Zhao, D. (2021). Pulmonary embolism after COVID-19 vaccination. Journal of Case Reports and Images in Medicine, 7, 1. https://doi.org/10.5348/100064z09ks2021cs doi:10.5348/100064Z09KS2021CS.
  27. Bouattour, N., Hdiji, O., Sakka, S., Fakhfakh, E., Moalla, K., Daoud, S., … Mhiri, C. (2021). Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurological Sciences, 43(2), 755–761. doi:10.1007/s10072-021-05733-x.
  28. Kodidela, S., Godse, S., Kumar, A., Nguyen, X. H., Cernasev, A., Zhou, L., … Kumar, S. (2022). Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality. Biology, 11(2), 177. doi:10.3390/biology11020177.
  29. Simnani, F. Z., Singh, D., & Kaur, R. (2021). COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review. 3 Biotech, 12(1). doi:10.1007/s13205-021-03076-0.
  30. YAZGAN, İ. (2021). Covid-19’a karşı mRNA SARS-CoV2 spesifik ve Çocukluk Dönemi Aşıları. Türk Doğa Ve Fen Dergisi, 10(2), 338–350. doi:10.46810/tdfd.994622.
  31. Nagalli, S., & Shankar Kikkeri, N. (2022). Sub-acute Onset of Guillain-Barré Syndrome Post-mRNA-1273 Vaccination: a Case Report. SN Comprehensive Clinical Medicine, 4(1). doi:10.1007/s42399-022-01124-1.
  32. Kubota, T., Hasegawa, T., Ikeda, K., & Aoki, M. (2021). Case Report: Isolated, unilateral oculomotor palsy with anti-GQ1b antibody following COVID-19 vaccination. F1000Research, 10, 1142. doi:10.12688/f1000research.74299.1.
  33. Walter, A., & Kraemer, M. (2021). A neurologist’s rhombencephalitis after comirnaty vaccination. A change of perspective. Neurological Research and Practice, 3(1). doi:10.1186/s42466-021-00156-7.
  34. Luca, A., Squillaci, R., Terravecchia, C., Contrafatto, F., Reggio, E., Nicoletti, A., & Zappia, M. (2021). Pure sensitive chronic inflammatory axonal polyneuropathy following Pfizer COVID-19 vaccine. Neurological Sciences. doi:10.1007/s10072-021-05696-z.
  35. Mohammed, R. A., Garout, R. M., Wahid, S., Ayub, F., Firas ZinAlddin, L. M., & Sultan, I. (2021). A Survey on the Side Effects of Pfizer/BioNTech COVID-19 Vaccine Among Vaccinated Adults in Saudi Arabia. Cureus. doi:10.7759/cureus.19222.
  36. Garg, R. K., & Paliwal, V. K. (2021). Spectrum of neurological complications following COVID-19 vaccination. Neurological Sciences. doi:10.1007/s10072-021-05662-9.
  37. Mohseni Afshar, Z., Babazadeh, A., Janbakhsh, A., Mansouri, F., Sio, T. T., Sullman, M. J. M., … Ebrahimpour, S. (2021). Coronavirus disease 2019 (Covid‐19) vaccination recommendations in special populations and patients with existing comorbidities. Reviews in Medical Virology. doi:10.1002/rmv.2309.
  38. Bax, F., Gigli, G. L., Belgrado, E., Brunelli, L., & Valente, M. (2021). Guillain–Barré syndrome following Covid-19 immunization: a report of two cases. Acta Neurologica Belgica. doi:10.1007/s13760-021-01798-9.
  39. Rao, S. J., Khurana, S., Murthy, G., Dawson, E. T., Jazebi, N., & Haas, C. J. (2021). A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine. Journal of Community Hospital Internal Medicine Perspectives, 11(5), 597–600. doi:10.1080/20009666.2021.1954284.
  40. Dalwadi, V., Hancock, D., Ballout, A. A., & Geraci, A. (2021). Axonal-Variant Guillian-Barre Syndrome Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine. Cureus. doi:10.7759/cureus.18291.
  41. Alghamdi, A., Ibrahim, A., Alraey, M., Alkazemi, A., Alghamdi, I., & Alwarafi, G. (2021). Side effects following COVID-19 vaccination: A cross-sectional survey with age-related outcomes in Saudi Arabia. Journal Of Advanced Pharmacy Education And Research, 11(3), 119–125. doi:10.51847/1UfXSzTR6M.
  42. Yang, Q., Lin, F., Wang, Y., Zeng, M., & Luo, M. (2021). Long Noncoding RNAs as Emerging Regulators of COVID-19. Frontiers in Immunology, 12. doi:10.3389/fimmu.2021.700184.
  43. Belopasov, V. V., Zhuravleva, E. N., Nugmanova, N. P., & Abdrashitova, A. T. (2021). Post-covid-19 neurological syndromes. Journal of Clinical Practice, 12(2), 69–82. doi:10.17816/clinpract71137.
  44. Olivieri, B., Betterle, C., & Zanoni, G. (2021). Vaccinations and Autoimmune Diseases. Vaccines, 9(8), 815. doi:10.3390/vaccines9080815.
  45. Theuriet, J., Richard, C., Becker, J., Pegat, A., Bernard, E., & Vukusic, S. (2021). Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: First report. Revue Neurologique. doi:10.1016/j.neurol.2021.04.005.
  46. Einstein, E. H., Shahzadi, A., Desir, L., Katz, J., Boockvar, J., & D’Amico, R. (2021). New-Onset Neurologic Symptoms and Related Neuro-Oncologic Lesions Discovered After COVID-19 Vaccination: Two Neurosurgical Cases and Review of Post-Vaccine Inflammatory Responses. Cureus. doi:10.7759/cureus.15664.
  47. Witman Tsur, S., Adrian Zaher, E., Tsur, M., Kania, K., & Kalinowska-Łyszczarz, A. (2021). Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All? International Journal of Molecular Sciences, 22(8), 3859. doi:10.3390/ijms22083859.

Article Research Metrics

We’ve partnered with Plum Analytics to track and display research metrics for each article. (All data provided by PlumX Metrics.) Click here to learn more about Plum Analytics.